Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

ObjectiveTo estimate the impact of using the Aptima messenger RNA (mRNA) high-risk human papilloma virus (HR-HPV) assay versus a DNA HR-HPV assay in a primary HPV cervical screening programme.DesignOne hypothetical cohort followed for 3 years through HPV primary cervical screening.SettingEngland.Par...

Full description

Bibliographic Details
Main Authors:	Maria Kyrgiou, Christina Founta, Georgie Weston, Caroline Dombrowski, Michael J Harvey, Thomas Iftner, Elisabeth J Adams
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-03-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/10/3/e031303.full

Similar Items

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
by: Max Chernesky, et al.
Published: (2017-06-01)

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada
by: Georgie Weston, et al.
Published: (2021-09-01)

Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.
by: Aniek Boers, et al.
Published: (2014-01-01)

Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening
by: Hye-young Wang, et al.
Published: (2019-01-01)

Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection
by: Anna Pańczyszyn, et al.
Published: (2020-01-01)

Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo
by: Akouélé P. Kuassi-Kpede, et al.
Published: (2021-03-01)

Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
by: Pornjarim Nilyanimit, et al.
Published: (2017-10-01)

Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
by: Lina Wang, et al.
Published: (2016-01-01)

Comparative study of a novel application of automated HR HPV assay and stability in a previously untested Preservative media
by: Mike E. Morel, et al.
Published: (2017-12-01)

Cervical and Oral Screening for HR-HPV types 16 and 18 among Sudanese Women Cervical Lesions
by: Elasbali Abdelbaset Mohamed, et al.
Published: (2012-07-01)

An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
by: Wai Sing Chan, et al.
Published: (2020-05-01)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM.
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019-01-01)

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens
by: Thomas Iftner, et al.
Published: (2016-11-01)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
by: Xushan Cai, et al.
Published: (2019-08-01)

Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection
by: Avalon Ernstson, et al.
Published: (2020-02-01)

Effect of paiteling on the alteration of persistent HR-HPV infection after panhysterectomy
by: Ye Zhao, et al.
Published: (2018-12-01)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
by: Antonio Carlos de Freitas, et al.
Published: (2017-05-01)

Efficacy in Treatment of Cervical HrHPV Infection by Combination of Beta Interferon, and Herbal Therapy in Woman with Different Cervical Lesions
by: Ermina Iljazović, et al.
Published: (2008-11-01)

Performance of the Xpert HPV assay in women attending for cervical screening
by: Jack Cuzick, et al.
Published: (2015-12-01)

Effect of hrHPV infection on anti-apoptotic gene and pro-apoptotic gene expression in cervical cancer tissue
by: Min-Er Tang
Published: (2016-09-01)

Screening of high-risk human papillomavirus (HR HPV) in Centro Hospitalar do Baixo Vouga, E.P.E., Portugal
by: P. Matos, et al.
Published: (2020-12-01)

Comparison of PANA RealTyper HPV Kit with AdvanSure HPV GenoBlot Assay for Human Papillomavirus Genotyping
by: Yi Hyeon Kim, et al.
Published: (2018-12-01)

Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor
by: Tynisha S. Rafael, et al.
Published: (2021-06-01)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
by: Liu Q, et al.
Published: (2021-09-01)

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
by: Wei Zhang, et al.
Published: (2020-10-01)

Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections.
by: Adolfo de Salazar, et al.
Published: (2019-01-01)

Evaluation of hrHPV testing on a vaginal specimen collected by woman her-self in Bolivia
by: Allende Larrain, Gustavo
Published: (2020)

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions
by: M I Zubillaga-Guerrero, et al.
Published: (2013-01-01)

Cytokine genes polymorphisms of TNF, IFN-y and IL-12 as potential predictors in the onset of cervical disease associated with HR HPV infections
by: Tasić Dijana, et al.
Published: (2015-01-01)

PCR-RFLP assay as an option for primary HPV test
by: L. Golfetto, et al.
Published: (2018-03-01)

The role of STAT3 during the human papillomavirus (HPV) life cycle and in HPV-associated cervical cancer
by: Morgan, Ethan Luc
Published: (2018)

Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
by: Federica Zito Marino, et al.
Published: (2020-07-01)

Comparison of the Tellgenplex HPV DNA test with the PCR-reverse dot blot assay for human papillomavirus genotyping
by: Ya-Chao Yao, et al.
Published: (2018-01-01)

CLINICAL IMPACT AND IMPLICATION OF HUMAN PAPILLOMAVIRUS (HPV) IN CERVICAL CANCER
by: Lilian Pustan, et al.
Published: (2007-12-01)

Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays
by: Mette Tranberg, et al.
Published: (2020-12-01)

Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.
by: Ralph-Sydney Mboumba Bouassa, et al.
Published: (2018-01-01)

A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology
by: Jiaojiao Gong, et al.
Published: (2021-06-01)

Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.
by: Sarah Preisler, et al.
Published: (2013-01-01)

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
by: Yuanhang Zhu, et al.
Published: (2019-03-01)

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
by: Theodoros Agorastos, et al.
Published: (2015-01-01)